United States · Series C startup
7 rounds we have observed, with the 8 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$107Mraised across 7 rounds since 2008, from 7 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
From a historical funding recordSEC filing: $68M sold, first sale Sept 2014
No investor was named in the report.
From a historical funding recordSEC filing: $5.0M sold, first sale Jun 2014
Reported by xconomy.comSEC filing: $10M sold, first sale Sept 2013
Reported by pevc.dowjones.comSEC filing: $12M sold, first sale Jun 2012
Reported by bionanogenomics.com
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Domain Associates
Declaration PartnersKT Venture Group
Legend Capital
Novartis Venture FundInnovation Valley Partners
21VenturesMissing a round, or an investor who was in one? Tell us.
These 2 firms list BioNano Genomics as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.
BioNano Genomics's investors include Battelle Ventures, Domain Associates, Declaration Partners, KT Venture Group and Legend Capital, and 3 more on record.
BioNano Genomics has raised $107M across 7 rounds since 2008.
BioNano Genomics's most recent round was a Series C of $53M in Nov 2014.
Its most recent round, $53M in Nov 2014, is also its largest on record.
BioNano Genomics's first round on record, in Mar 2008, was backed by Battelle Ventures, KT Venture Group and 21Ventures.
BioNano Genomics's latest named round is a Series C, in Nov 2014.
BioNano Genomics is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United States · 
